[{"id":"10b2179b-52da-4e46-b9e4-4e75a4ef6fac","acronym":"TheraVACCS","url":"https://clinicaltrials.gov/study/NCT02750202","created_at":"2021-01-29T07:12:03.463Z","updated_at":"2024-07-02T16:35:04.901Z","phase":"Phase 3","brief_title":"Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts","source_id_and_acronym":"NCT02750202 - TheraVACCS","lead_sponsor":"University of Pretoria","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 75","initiation":"Initiation: 07/01/2018","start_date":" 07/01/2018","primary_txt":" Primary completion: 05/31/2025","primary_completion_date":" 05/31/2025","study_txt":" Completion: 07/31/2025","study_completion_date":" 07/31/2025","last_update_posted":"2024-05-08"},{"id":"d9114b60-2d89-4f99-a047-86f0c086a77b","acronym":"","url":"https://clinicaltrials.gov/study/NCT00667563","created_at":"2021-01-29T06:58:27.993Z","updated_at":"2024-07-02T16:35:14.181Z","phase":"Phase 1","brief_title":"Vaccine Therapy in Preventing HPV in HIV-Positive Women in India","source_id_and_acronym":"NCT00667563","lead_sponsor":"AIDS Malignancy Consortium","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine)"],"overall_status":"Completed","enrollment":" Enrollment 150","initiation":"Initiation: 08/01/2009","start_date":" 08/01/2009","primary_txt":" Primary completion: 11/01/2012","primary_completion_date":" 11/01/2012","study_txt":" Completion: 11/01/2012","study_completion_date":" 11/01/2012","last_update_posted":"2024-03-19"},{"id":"eec6641e-d7f1-4cf2-9f0b-8bb018518b55","acronym":"","url":"https://clinicaltrials.gov/study/NCT04096911","created_at":"2021-01-18T20:02:48.732Z","updated_at":"2024-07-02T16:36:55.395Z","phase":"Phase 2","brief_title":"Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer","source_id_and_acronym":"NCT04096911","lead_sponsor":"Buhai Wang","biomarkers":" PD-L1","pipe":"","alterations":" ","tags":["PD-L1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • Tyvyt (sintilimab) • Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine)"],"overall_status":"Unknown status","enrollment":" Enrollment 20","initiation":"Initiation: 07/31/2019","start_date":" 07/31/2019","primary_txt":" Primary completion: 03/31/2021","primary_completion_date":" 03/31/2021","study_txt":" Completion: 03/31/2021","study_completion_date":" 03/31/2021","last_update_posted":"2019-09-20"}]